Uveal melanoma: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

ESMO Open 2026 Open access

Read full text
Authors: S. Piperno-Neumann, M. Angi, P.A. Ascierto, J.F. Baurain, M.C. Burgmans, N. Cassoux, S.E. Coupland, R. Dendale, A. Fortuna, L. Gastaud, C. Gutierrez-Miguelez, S. Heegaard
+19 more M.J. Jager, E. Kapiteijn, U. Keilholz, E. Kilic, M. Marinković, A. Moulin, P. Nathan, S.P. Patel, A. Pica, J.M. Piulats, B. Ryll, J.J. Sacco, W. Sauerwein, M. Schlaak, B. Stedman, A. Valente, R.M. Verdijk, C. Verhoef, O. Michielin
DOI: 10.1016/j.esmoop.2026.106888
Cited by: 2
References: 120

Abstract

Uveal melanoma (UM) is associated with specific challenges due to its rare incidence. Optimal management of the disease requires multidisciplinary collaboration and coordination for the diagnosis, treatment, follow-up and support of patients at all stages and clearly established referral pathways.1 All patients should have access to centres with dedicated expertise in primary and metastatic UM either nationally or through cross-border access agreements, using the potential of the existing and forthcoming European Reference Networks as outlined in Europe’s Beating Cancer Plan, the ambition of the European Union (EU) Cancer Mission and the establishment and connection of Comprehensive Cancer Care Infrastructures in the EU.

Fields of Study & Subjects

Ocular Oncology and Treatments Cutaneous Melanoma Detection and Management Ocular Disorders and Treatments

Publication details

Journal / source
ESMO Open
Publisher
Elsevier BV
Volume
11
Issue
4
Pages
106888–106888
Publication date
1 April 2026
Language
EN